Article
Prescription startup NowRx is crowdfunding its latest $73 million funding round. Here's why CEO Cary Breese decided to avoid VCs.
Rating:
0.0
Views:
57
Likes:
1
Library:
1
NowRx's CEO sees several benefits to crowdfunding, like not getting pressure from VCs to scale too quickly and gaining a marketing advantage.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value